Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.4605
+0.0045 (0.99%)
Mar 17, 2026, 10:15 AM EDT - Market open

Gossamer Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-156.16-56.53-179.82-229.38-234-243.36
Depreciation & Amortization
1.854.154.394.435.174.27
Stock-Based Compensation
12.6220.6228.5242.5532.0138.75
Other Adjustments
-8.4-11.172.6-0.187.1727.08
Change in Receivables
-2.66-5.34----
Changes in Accounts Payable
-4.49-1.663.99-1.81-4.436.98
Changes in Accrued Expenses
10.16-6.48-12.02-0.626.2-6.12
Changes in Unearned Revenue
-13.0555.92----
Changes in Other Operating Activities
-5.89-2.99-6.81-2.03-1-3.96
Operating Cash Flow
-158.43-3.47-159.16-187.03-188.89-176.36
Capital Expenditures
-0.08---0.41-1.55-1.5
Purchases of Investments
-289.8-494.78-441.67-238.06-152.03-108.97
Proceeds from Sale of Investments
426.3523.8330.7237.536.23349.19
Payments for Business Acquisitions
----0.07-0.08-23.38
Investing Cash Flow
136.4229.02-110.97-1.04-117.43215.34
Long-Term Debt Issued
-----193.6
Long-Term Debt Repaid
--12.58-11.61-5.81--
Net Long-Term Debt Issued (Repaid)
--12.58-11.61-5.81-193.6
Issuance of Common Stock
1.861.09201.77122.93.33118.94
Net Common Stock Issued (Repurchased)
1.861.09201.77122.93.33118.94
Financing Cash Flow
2.61-11.49190.15117.093.33312.54
Effect of Exchange Rate Changes on Cash and Cash Equivalents
0.01-0.10.11-0.52-0.170.01
Net Cash Flow
-19.5313.97-79.86-71.49-303.15351.53
Free Cash Flow
-158.51-3.47-159.16-187.44-190.44-177.86
FCF Margin
-359.84%-3.02%----
Free Cash Flow Per Share
-0.70-0.02-1.04-2.22-2.54-2.60
Levered Free Cash Flow
-205.94-20.16-201.89-235.62-229.61-50.09
Unlevered Free Cash Flow
-208.64-11.93-194.22-219.03-211.73-234.29
Updated Nov 5, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q